-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary14/lung-cancer-screening
March 09, 2021 - emphysema, infectious and inflammatory processes, masses, nodules, or cysts of the kidney, breast, adrenal, liver … infectious and inflammatory processes; and masses, nodules, or cysts of the kidney, breast, adrenal, liver
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/latent-tuberculosis-infection-screening
May 02, 2023 - were very rare—a total of 3 participants in IUAT, all of whom had continued to take isoniazid after liver … Isoniazid chemoprophylaxis: association with detection and incidence of liver toxicity.
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/anticoagulants-1.pdf
March 01, 2020 - given to a patient based on specific criteria (e.g., patient characteristics such as weight,
kidney or liver … Dosing protocols or nomograms may
reflect different patient characteristics, such as kidney or liver
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary19/high-blood-pressure-in-adults-screening-monitoring-october-2015
December 22, 2014 - Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up,
-
effectivehealthcare.ahrq.gov/health-topics/spleen-diseases
-
effectivehealthcare.ahrq.gov/health-topics/hodgkin-disease
-
effectivehealthcare.ahrq.gov/health-topics/organ-donation
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/KFZpoMBYuoo8TRW6nhRev8
October 23, 2023 - eTables 1-4 in the Supplement).6,7 There were also no dif-
ferences in risk of grade 2 or 3 kidney or liver … events, discontinua-
tion due to liver-related adverse events, or STIs. … Liver and
renal safety of tenofovir disoproxil fumarate in
combination with emtricitabine among African
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-preventive-medication
April 26, 2022 - factors include male sex, diabetes, history of gastrointestinal issues (such as peptic ulcer disease), liver
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/obesity-child_research-protocol.pdf
March 31, 2010 - including type 2 diabetes, hypertension, high cholesterol, stroke, heart disease, nonalcoholic fatty
liver
-
www.ahrq.gov/sites/default/files/2024-01/field-report.pdf
January 01, 2024 - Liver and thyroid monitoring in ambulatory patients
prescribed amiodarone in 10 HMOs.
-
www.ahrq.gov/sites/default/files/2024-02/mackenzie-report.pdf
January 01, 2024 - Major organ lacerations, including injury to the lung,
stomach, spleen, left lobe of the liver, and
-
www.ahrq.gov/hai/cusp/toolkit/content-calls/empowerment.html
April 01, 2013 - So our pavilion decided to concentrate on pancreatic and liver cancer patients, even though it’s in the
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/impact-healthcare-algorithms-racial-ethnic-disparities-March-2.pdf
May 15, 2023 - Study
Designa
Disparities in
Health outcomeb
Disparities in
Accessb
Disparities in
Qualityb
Liver
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/obesity-in-children-and-adolescents-screening-june-2017
June 20, 2017 - Trials showed no differences in kidney or liver function.
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/obesity-in-adults-interventions
September 18, 2018 - with obesity include ischemic heart disease, type 2 diabetes, respiratory diseases, and cancer (eg, liver
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/r77BgfGVeBPRDME-DpBvFk
April 08, 2025 - Primary Care Behavioral Counseling Interventions to Support Breastfeeding: US Preventive Services Task Force Recommendation Statement
Primary Care Behavioral Counseling Interventions to Support Breastfeeding
US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force
Summary of Recom…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-kidney-disease-anemia-2011_research-protocol.pdf
January 01, 2011 - and manage iron-
deficiency anemia
Outcomes:
o Mortality
o Morbidity (e.g. cardiac or liver
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol1/Advances-Shimada_65.pdf
April 04, 2008 - without chronic complications, diabetes with chronic complications,
hypothyroidism, renal failure, liver
-
hcup-us.ahrq.gov/datainnovations/Challenges_and_Opportunities_ICD10CMPCS.pdf
October 01, 2014 - qualifier DIAGNOSTIC is
used to identify excision
procedures that are biopsies
Partial nephrectomy,
liver